Chronic Myelogenous Leukemia with the e6a2 BCR-ABL and Lacking Imatinib Response: Presentation of Two Cases

Publisher： Karger

E-ISSN： 1421-9662|122|1|11-16

ISSN： 0001-5792

Source： Acta Haematologica, Vol.122, Iss.1, 2009-07, pp. : 11-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Imatinib Mesylate Resistance in a Chronic Myeloid Leukemia Patient with a Novel e8a2 BCR-ABL Transcript Variant

By  

Acta Haematologica, Vol. 120, Iss. 3, 2008-11 ,pp. : 146-149

Karger

Access to resources Recommend Favorite

Coexistence of JAK2V617F Mutation and BCR-ABL1 Transcript in Two Chinese Patients with Chronic Myelogenous Leukemia

By  

Acta Haematologica, Vol. 127, Iss. 1, 2011-10 ,pp. : 47-49

Karger

Access to resources Recommend Favorite

BCR-ABL in Chronic Myelogenous Leukemia – How Does It Work?

By  

Acta Haematologica, Vol. 119, Iss. 4, 2008-06 ,pp. : 212-217

Karger

Access to resources Recommend Favorite

Detection of the BCR-ABL Fusion Gene in Natural Killer Cells in Patients with Chronic Myelogenous Leukemia

By  

Acta Haematologica, Vol. 104, Iss. 2-3, 2001-01 ,pp. : 135-138

Karger

Access to resources Recommend Favorite

Case study of primary imatinib resistance and correlation of BCR-ABL multiple mutations in chronic myeloid leukemia

By Iqbal Zafar   Siddiqui Rubina T   Qureshi Javed A   Khalid Ahmad M  

Therapy, Vol. 1, Iss. 2, 2004-11 ,pp. : 249-254

Future Medicine

Access to resources Recommend Favorite